ArticleCancer medicine2025
Correction to "Better Response and Prognosis of Venetoclax Plus Hypomethylating Agents Over Intensive Chemotherapy in Young Adults With Newly Diagnosed ASXL1-Mutated Acute Myeloid Leukemia".
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.